Michael Nierenberg’s Unrivaled Managerial Aptitude

New Residential Investment Corp Board of Directors concluded that Michael Nierenberg is a deserving Chairman of the Board of Director in 2016. He is also the serving President and CEO in the same company. Michael Nierenberg owns more than 60,000 units at NRZ stock worth over US$16 million. His total estimated net worth is over US$16.5 million as of February this year. Since 2016, Michael Nierenberg has made over four stock trades. In 2018 only, Michael managed the acquisition of over 1.5 million units worth over US$ 25.5 million. Michael Nierenberg’s success did not come on a silver platter. His hard work and determination are what gave him his fortune. His managerial career began at Lehman Brothers where he stayed for seven years. He was a crucial influence in re-establishment of the firm’s adjustable rates in the mortgage business.

Michael Nierenberg joined Bear Stearns and was made a Board of Directors member from 2006 to 2008. He also co-headed mortgage-backed securities trading and structured products and headed foreign exchange trading and interest rate operations. His work at Bear Stearns lasted fourteen years. Later, Michael Nierenberg was employed at JP Morgan and led the Global Securitized Products. He was also a member of the management committee. In November 2008, Michael left JP Morgan for the Bank of America Merrill Lynch. He was the head of Global Mortgages and Securitized Products Division as well as the Managing Director. All these positions honed Michael’s managerial skills which at NRZ assisted him in holding the three positions. Michael is also the Managing Director at Fortress.

To know more click: here.

Michael Nierenberg: Business and Philanthropy

The New Residential Investment Corp. is a real estate investment trust that is available for public trading. And the New Residential Investment Corp. is focused on managing and investing in residential real estate. New Residential Investment Corp. is a company that is ready to take high risks in order to build high profit as well. The investments of New Residential Investment Corp. usually is spread between non-Agency residential mortgage backed securities or what they call “RMBS”, Associated Call Rights and Excess Mortgage Servicing Rights or “MSRs”.

It is known and proven that the investment expertise and the prowess of New Residential Investment Corp. in the industry isunparred with. New Residential Investment Corp. focuses on long term cashflows that can generate a significant and certain income in the future.

New Residential Investment Corp. is ran by Michael Nierenberg. He is the current Chairman, Chief Executive Officer, and President of New Residential Investment Corporation. Under Michael Nierenberg’s leadership of New Residential Investment Corp., it is now currently valuated at about 14 million dollars with about a million dollars in equity value.

Michael Nierenberg is such an effective leader because of his extensive experience and knowledge in different approaches for investments because of his past experiences with other companies. He has served in the biggest names in the investment industry and he is already a household name in the industry.

Michael Nierenberg is not only an excellent business man, he also forwards his philanthropy and he is an active member of the community. Michael Nierenberg is also the current chairman of the Samuel Waxman Cancer Research Foundation. The Samuel Waxman Cancer Research Foundation is one of the front runners in developing and innovating treatment and technologies that focus on reprogramming the behavior of cancer cells. The scientists of the Samuel Waxman Cancer Research Foundation were the pioneers in sing differentiation therapy to cure an acute form of leukemia. The Samuel Waxman Cancer Research Foundation still continues to work in forwarding newer technologies in curing different kinds of cancer and the Samuel Waxman Cancer Research Foundation supports other organizations that are also focused on developing new treatments for cancer.

Michael Nierenberg’s: Twitter

The Sky is the Limit for GreenSky

After being added to Forbes’ top 50 FinTech companies, it is no wonder that the Atlanta-based lending innovator, GreenSky is being recognized as an industry leader. The company is still young and growing. A successful IPO this year means that the sky is truly the limit for GreenSky.

GreenSky recently went public in which they raised $824 million in capital to do so. The company’s hard work of the last 12 years since inception is finally starting to pay off in big ways. Much of the original team is still involved as primary owners of the firm.

The company has quickly moved to the forefront as one of the juggernauts of the FinTech industry. The company has also become one of the most profitable financial technology startups in the nation. GreenSky acts as a middleman for pitching loans to banks so it differentiates itself from the old industry leaders like Lending Club.

Not just a typical loan organization, GreenSky transfers much of the risk for everyday people taking on loans to its capital-saturated bank partners, like SunTrust, Regions and Fifth Third, who fund these loans. GreenSky is not responsible for any defaults. However, this is how the company makes profits; the banks pay the firm about 1 % each year for managing the loans.

The company’s business strategy is much like a payment industry company’s such as Visa or Mastercard’s business model. All of these companies act as intermediaries or as a lender although in a credit card situation it is a little different than from an outright loan. This industry is expected to grow into 2019 as people accept new options for taking on loans as opposed to credit.

The future is bright for the young company because it is now evolving into different markets. They now offer loans for healthcare solutions which is a highly sought after monetary loan purpose. Many people find themselves in a pickle when paying for ever-rising healthcare costs, but the loan company makes it easy on everyone to access payments for their necessary healthcare expenses.